Tenet Healthcare reported financial results for the first quarter of 2006 with net income of $15 million. While pricing increases helped offset revenue declines from falling volumes, particularly in commercial managed care, weak volumes continued to be a major challenge affecting profits. The company reported improvements in quality metrics and cost controls but significant cash outflows in the quarter due to unusual payments for litigation, restructuring, and 401k matching contributions. Tenet aims to boost volumes through quality initiatives to gain designations as Centers of Excellence from major health plans and consumer incentives for policyholders.
Quest Diagnostics held a conference call to discuss financial results for the third quarter of 2008. Key points included:
- Revenues grew 3.4% to $1.8 billion, adjusted earnings per share increased 12%, and cash flow improved to $329 million.
- Guidance for full year 2008 was raised for adjusted earnings per share to between $3.17-$3.22.
- The company reached an agreement in principle with the federal government regarding an investigation, increasing related reserves by $73 million.
- Growth was driven by increases in esoteric, gene-based, and routine testing. Progress was also made on cost reduction initiatives.
Trevor Fetter, CEO of Tenet Healthcare, discussed the company's strong Q2 2008 results. Same-hospital admissions grew 2.2%, the best result in over 4 years. Excluding recently divested hospitals, core same-hospital admissions grew 2.2% and paying admissions grew 2.2%. Commercial managed care admissions declined 1.7% but grew 1.9% in targeted service lines. Fetter also outlined several hospital divestitures and asset sales that would generate $750-950 million in cash, most of which would be used to retire debt. This would reduce EBITDA but increase pre-tax income and free cash flow.
Stephen Newman, also of Tenet Healthcare, provided
During the quarter, Quest Diagnostics delivered strong growth in revenues and earnings, making progress on their strategic plan. Revenues grew 17% to $1.8 billion and earnings per share increased 31%. They drove organic revenue growth, further aligned AmeriPath, saw double-digit growth in near-patient testing, continued reducing costs, and opened a new lab in India. Guidance for 2008 remains unchanged with expected revenue growth of 9% and earnings per share between $3.00-$3.20, excluding potential special charges.
Quest Diagnostics reported strong financial results for Q3 2007, with revenues growing 11.6% to $1.8 billion and operating margins improving to 17.3%. While volumes declined 2.4% due to losing a contract with UnitedHealthcare, revenue per requisition increased 13.3% and margins returned to pre-contract levels within 9 months. Quest also provided full-year 2007 guidance, expecting revenues of $6.6-6.7 billion and operating margins of 16%, and is focused on driving growth through new tests, acquisitions, and expanding patient and physician services.
- Cardinal Health reported financial results for Q2 FY2017 with total revenue of $33.15 billion, a 5% increase over the prior year. Operating earnings were $542 million, a 4% decrease.
- The Pharmaceutical segment saw 5% revenue growth but a 14% decline in segment profit due to generic drug pricing and loss of a customer. The Medical segment had 8% revenue growth and 50% increase in segment profit driven by contributions from Cordis.
- For FY2017, Cardinal expects revenue growth in the high-single digits and non-GAAP diluted EPS between $5.35-$5.50, up from $5.24 in FY2016. The Pharmaceutical segment outlook
Dsp Investor deck jan 2016 JP Morgan finalDiplomatIR
Diplomat is a leading independent specialty pharmacy focused on providing exceptional patient care and clinical services. It has experienced strong growth, with revenues increasing over 120% since its IPO and EBITDA growing nearly 400% over the same period. Diplomat has a unique position in the specialty pharmacy industry as it continues to gain exclusive access to limited distribution drugs and expand into complementary service areas, while large PBMs are increasingly excluded from such opportunities. It has strengthened its leadership team through strategic hires and acquisitions to support its diversification and national expansion.
- Cardinal Health reported Q4 FY2017 revenue of $32.966 billion, a 5% increase over the prior year. Operating earnings were $439 million, a 29% decrease.
- Revenue in the Pharmaceutical segment increased 5% to $29.552 billion driven by distribution customer and specialty solutions growth. Segment profit decreased 7% to $505 million due to generic pricing and IT investment.
- The Medical segment saw 6% revenue growth to $3.416 billion from new and existing customers. Segment profit rose 13% to $138 million from post-acute solutions and distribution growth.
- Cardinal Health reported financial results for Q1 FY2018 with total revenue of $32.6 billion, a 2% increase over Q1 FY2017. However, operating earnings were $262 million, a 51% decrease from the previous year.
- Earnings per share for Q1 FY2018 were $0.36, down 63% from the prior year. The decreases in operating earnings and EPS were driven by lower generics program performance and costs associated with IT platform investments.
- The Pharmaceutical segment saw a 1% revenue increase but a 13% decrease in segment profit due to generics pricing changes partially offset by benefits from the Red Oak Sourcing venture. The Medical segment reported 14% revenue growth
Quest Diagnostics held a conference call to discuss financial results for the third quarter of 2008. Key points included:
- Revenues grew 3.4% to $1.8 billion, adjusted earnings per share increased 12%, and cash flow improved to $329 million.
- Guidance for full year 2008 was raised for adjusted earnings per share to between $3.17-$3.22.
- The company reached an agreement in principle with the federal government regarding an investigation, increasing related reserves by $73 million.
- Growth was driven by increases in esoteric, gene-based, and routine testing. Progress was also made on cost reduction initiatives.
Trevor Fetter, CEO of Tenet Healthcare, discussed the company's strong Q2 2008 results. Same-hospital admissions grew 2.2%, the best result in over 4 years. Excluding recently divested hospitals, core same-hospital admissions grew 2.2% and paying admissions grew 2.2%. Commercial managed care admissions declined 1.7% but grew 1.9% in targeted service lines. Fetter also outlined several hospital divestitures and asset sales that would generate $750-950 million in cash, most of which would be used to retire debt. This would reduce EBITDA but increase pre-tax income and free cash flow.
Stephen Newman, also of Tenet Healthcare, provided
During the quarter, Quest Diagnostics delivered strong growth in revenues and earnings, making progress on their strategic plan. Revenues grew 17% to $1.8 billion and earnings per share increased 31%. They drove organic revenue growth, further aligned AmeriPath, saw double-digit growth in near-patient testing, continued reducing costs, and opened a new lab in India. Guidance for 2008 remains unchanged with expected revenue growth of 9% and earnings per share between $3.00-$3.20, excluding potential special charges.
Quest Diagnostics reported strong financial results for Q3 2007, with revenues growing 11.6% to $1.8 billion and operating margins improving to 17.3%. While volumes declined 2.4% due to losing a contract with UnitedHealthcare, revenue per requisition increased 13.3% and margins returned to pre-contract levels within 9 months. Quest also provided full-year 2007 guidance, expecting revenues of $6.6-6.7 billion and operating margins of 16%, and is focused on driving growth through new tests, acquisitions, and expanding patient and physician services.
- Cardinal Health reported financial results for Q2 FY2017 with total revenue of $33.15 billion, a 5% increase over the prior year. Operating earnings were $542 million, a 4% decrease.
- The Pharmaceutical segment saw 5% revenue growth but a 14% decline in segment profit due to generic drug pricing and loss of a customer. The Medical segment had 8% revenue growth and 50% increase in segment profit driven by contributions from Cordis.
- For FY2017, Cardinal expects revenue growth in the high-single digits and non-GAAP diluted EPS between $5.35-$5.50, up from $5.24 in FY2016. The Pharmaceutical segment outlook
Dsp Investor deck jan 2016 JP Morgan finalDiplomatIR
Diplomat is a leading independent specialty pharmacy focused on providing exceptional patient care and clinical services. It has experienced strong growth, with revenues increasing over 120% since its IPO and EBITDA growing nearly 400% over the same period. Diplomat has a unique position in the specialty pharmacy industry as it continues to gain exclusive access to limited distribution drugs and expand into complementary service areas, while large PBMs are increasingly excluded from such opportunities. It has strengthened its leadership team through strategic hires and acquisitions to support its diversification and national expansion.
- Cardinal Health reported Q4 FY2017 revenue of $32.966 billion, a 5% increase over the prior year. Operating earnings were $439 million, a 29% decrease.
- Revenue in the Pharmaceutical segment increased 5% to $29.552 billion driven by distribution customer and specialty solutions growth. Segment profit decreased 7% to $505 million due to generic pricing and IT investment.
- The Medical segment saw 6% revenue growth to $3.416 billion from new and existing customers. Segment profit rose 13% to $138 million from post-acute solutions and distribution growth.
- Cardinal Health reported financial results for Q1 FY2018 with total revenue of $32.6 billion, a 2% increase over Q1 FY2017. However, operating earnings were $262 million, a 51% decrease from the previous year.
- Earnings per share for Q1 FY2018 were $0.36, down 63% from the prior year. The decreases in operating earnings and EPS were driven by lower generics program performance and costs associated with IT platform investments.
- The Pharmaceutical segment saw a 1% revenue increase but a 13% decrease in segment profit due to generics pricing changes partially offset by benefits from the Red Oak Sourcing venture. The Medical segment reported 14% revenue growth
1) Quest Diagnostics reported strong financial results for Q4 and full year 2007, with consolidated revenues growing 14.3% to $1.8 billion in Q4. Operating margin grew to 17.6% and cash flow was $355 million for the quarter.
2) For 2008, Quest expects revenue growth of approximately 9%, operating income as a percentage of revenues to approach 17%, cash from operations of $900 million, and diluted EPS between $3.00-$3.20, excluding potential special charges.
3) Quest aims to grow revenues above industry rates, expand operating income to 20% of revenues, and derive 10% of revenues from international business within 5 years. The company is well
Impax provides a summary of its business and priorities for 2017. It has a specialty pharmaceutical division focused on branded CNS products including Rytary for Parkinson's disease. Its generics division has a diversified portfolio of 72 commercial products. For 2017, Impax aims to focus on quality, execute growth initiatives for specialty products, maximize profits from generics, launch new generics, and further diversify and reduce expenses.
Sovereign Bancorp reported financial results for the fourth quarter and full year of 2007. For Q4, the company reported a net loss of $1.6 billion compared to a net loss of $129 million in Q4 2006, primarily due to goodwill impairments. For the full year, Sovereign reported a net loss of $1.3 billion compared to net income of $137 million in 2006. The company is taking steps to strengthen its capital position such as discontinuing its dividend and reducing expenses. Sovereign's non-performing loans increased and net interest margin expanded in Q4.
Sovereign Bancorp reported first quarter 2008 results with net income of $100.1 million, up from $48.1 million in the first quarter of 2007. Key highlights included an increase in net interest margin to 2.88% and loan growth of 1.9%. Non-performing loans increased to $417.8 million due to higher non-performing commercial loans related to the housing market. The allowance for credit losses was increased to 1.36% of total loans. Sovereign's President and CEO stated that results demonstrate progress reducing risk and improving earnings quality, but that turbulent financial markets provide a challenging credit environment.
This document summarizes a conference call by Quest Diagnostics about their third quarter 2005 financial results. Key points include:
- Revenues grew 6.4%, earnings per share were $0.66, and cash flow was $178 million.
- Clinical testing revenues grew 7.1% due to increased volume and revenue per test. Hurricanes Katrina and Rita reduced revenues by 0.5%.
- Operating income was 17.7% of revenues compared to 18% last year. Margins increased in clinical testing but were reduced by hurricanes and a $6.2 million charge.
- Their test kit manufacturing subsidiary NID performed below last year, reducing revenue growth by 0.5% and margin expansion
United Health Group[PDF Document] Earnings Releasefinance3
UnitedHealth Group reported first quarter 2008 results, with revenues increasing 7% to $20.3 billion and people served growing by 2 million to 73 million. Operating margin was 8.4% and net earnings per share grew 5% to $0.78. However, the company reduced its full-year 2008 outlook by 10% to a range of $3.55-$3.60 per share due to higher than expected medical costs and lower investment income. The company remains committed to $4 billion in share repurchases for 2008.
Fifth Third Bancorp reported an 11% increase in fourth quarter earnings per share compared to the same period last year. Net income for the fourth quarter totaled $423 million, a 10% increase over fourth quarter 2001. For the full year 2002, earnings per share increased 48% over 2001. The bank experienced strong customer and deposit growth, solid revenue and loan growth, and consistent credit quality. Looking ahead to 2003, the bank expects continued positive growth while remaining prepared for economic challenges.
The document provides an earnings summary and outlook for Q2 2016. Key points include:
- Adjusted EPS was above guidance despite a challenging macro environment.
- Transportation orders remained solid while Industrial orders grew quarter-over-quarter.
- Guidance for Q3 2016 projects adjusted EPS growth of 14% year-over-year.
- Full year 2016 guidance reiterates sales of $12.1-12.5 billion and adjusted EPS of $3.90-4.10.
UGI Corporation reported record results for the first quarter of fiscal year 2017. Adjusted earnings per share increased 42% compared to the prior year period, driven by higher adjusted net income across all four business units. AmeriGas Propane reported a 3.6% increase in retail volumes and $4 million decrease in operating expenses despite warmer weather. UGI International benefited from increased bulk volume due to colder weather. Midstream & Marketing saw higher margins from natural gas and capacity management. Utilities reported a 32.2% increase in core market volumes and margin growth from higher rates. Overall, strong execution and contributions from strategic investments led to the company's best ever first quarter financial performance.
Owens Corning presented at an investor event on June 13, 2017. The presentation focused on Owens Corning's commitment to shareholder value and provided an overview of the company's three business segments. Owens Corning has improved its portfolio and financial profile in recent years through cost reductions, acquisitions, and growth in higher-margin businesses. This has increased the company's adjusted EBIT margins and return on capital. Owens Corning also has a strong cash flow outlook and disciplined capital allocation strategy to support growth and return cash to shareholders.
This document provides a summary of Malibu Boats' third quarter fiscal 2017 earnings results. It reported record third quarter net sales, units sold, net income and adjusted EBITDA. Net sales increased 12.6% year-over-year due to price increases and lower discounts offsetting a mix shift to new models. Gross profit grew 16.1% and gross margin increased to 27.7%. The US boating industry recovery continued in 2016 with over 11% growth, and Malibu Boats expects to continue expanding its market share leadership. For the full fiscal year, the company targets mid-single digit unit volume growth and modest increases in adjusted EBITDA margin and net sales per unit.
Aon reported strong results for the first quarter of 2017. Organic revenue grew 4%, operating margin expanded 220 basis points to 22.3%, earnings per share increased 20% to $1.45, and free cash flow grew 38% to $148 million. Aon is a leading global professional services firm that provides risk, retirement, and health solutions using proprietary data and analytics to help clients reduce volatility and improve performance.
- TE Connectivity reported record Q3 adjusted EPS of $1.08, up 20% year-over-year and above guidance.
- Sequential increases in revenue of 6% and orders of 7% were driven by growth in harsh environment businesses.
- For Q4, revenue is expected to be $3.35 billion at the mid-point with adjusted EPS of $1.20, including the impact of an extra week.
- Full year adjusted EPS guidance was reiterated at $4.00, up 11% year-over-year, on slightly reduced revenue of $12.25 billion at the mid-point.
- Phillips 66 Partners LP owns, operates, develops and acquires primarily fee-based crude oil, refined petroleum products and natural gas liquids pipelines and terminals and other midstream assets.
- PSXP has a balanced portfolio of assets with long-term, fee-based contracts providing stable cash flows. Recent acquisitions and organic growth projects will further expand the portfolio.
- PSXP is targeting 30% annual distribution growth through 2018 while maintaining investment grade credit ratings and annual distribution coverage of at least 1.1x.
- Owens Corning presented at investor events in May 2017 to discuss its Q2 2017 performance and focus on shareholder value.
- The presentation discussed Owens Corning's three business segments: Insulation, Roofing, and Composites, and emphasized its leadership positions, attractive end markets, and focus on improving margins, earnings, cash flow, and return on capital through portfolio improvements.
- Owens Corning has demonstrated significant improvement in its financial profile and cash flow generation over the past several years through repositioning its business portfolio.
General investor presentation september 2017irbgcpartners
BGC Partners provides an overview of its Financial Services segment. The segment includes voice/hybrid brokerage and fully electronic trading (FENICS). In 2Q 2017, voice/hybrid accounted for 87% of segment revenues and pre-tax distributable earnings were up 38% year-over-year with margins expanding over 500 basis points. Product revenues were diversified across rates, foreign exchange, credit, and other asset classes. BGC expects regulatory reform, rising interest rates, and a growing global economy to drive further opportunities in Financial Services.
UGI reported solid second quarter results despite warmer than normal weather. Earnings per share were $1.24, down from $1.31 in the prior year quarter but above expectations. Each of the company's business units - AmeriGas, UGI International, Midstream & Marketing, and UGI Utilities - experienced warmer weather but reported increased revenues through investments in less weather-dependent operations and a focus on efficiency. For the full year, UGI expects adjusted earnings per share to be at the lower end or slightly below its guidance range of $2.30 to $2.45, an improvement over fiscal year 2016 results.
- Wal-Mart reported third quarter fiscal year 2009 results, with net sales increasing 7.5% to $97.6 billion and income from continuing operations increasing 6.6% to $3.03 billion compared to the previous year.
- US comparable store sales increased 2.7% for Walmart and 4.5% for Sam's Club. International sales grew 11.2% and segment operating income increased 10.6%.
- For the full fiscal year, Wal-Mart estimates diluted earnings per share will be between $3.42-$3.46, lowered from previous guidance due to currency exchange rate impacts.
First quarter 2017 financial results and strategic priorities for TDS and its subsidiaries U.S. Cellular and TDS Telecom.
Key highlights include:
- U.S. Cellular reduced postpaid handset churn to 1.08%, launched new unlimited plans, and saw adjusted EBITDA rise 11%.
- TDS Telecom grew revenues across wireline, cable, and hosted/managed services segments and increased adjusted EBITDA 13%.
- Guidance for 2017 remains unchanged with goals of growing revenues, operating cash flow, and adjusted EBITDA for both companies.
- Aon reported 2% organic revenue growth in Q2 2015 for both its Risk Solutions and HR Solutions segments.
- Risk Solutions saw 4% organic growth in the Americas and solid growth in Asia, while HR Solutions saw 3% growth in both Consulting and Outsourcing.
- Operating margins increased 150 bps for Risk Solutions due to organic revenue growth and investments in data/analytics, while HR Solutions margins were flat as growth offset continued investments.
- EPS grew 11% excluding currency impacts, driven by operational improvements and share repurchases totaling $300 million.
This document outlines amended and restated bylaws for Terex Corporation. Key points include:
- Procedures for annual and special stockholder meetings, including requirements for submitting nominations of directors and proposals.
- Requirements for providing notice of stockholder meetings and fixing the record date.
- Quorum requirements and voting procedures for stockholder actions.
- Conduct of stockholder meetings and allowance for voting by proxy.
The document is a transcript of a conference call by Tenet Healthcare Corporation executives Trevor Fetter, Stephen Newman, and Biggs Porter on May 6, 2008 to discuss the company's financial results for the first quarter. Some key points:
1) Tenet saw positive same-hospital admissions growth for the second consecutive quarter and improved EBITDA margins, signs that the company's strategies are taking effect.
2) Physician recruitment efforts increased medical staff numbers and admissions from targeted physicians. Commercial pricing also improved due to contract negotiations.
3) Cost control measures helped boost profits. April volumes showed continued growth in admissions and outpatient visits.
4) Financial results met or exceeded expectations, putting Ten
1) Quest Diagnostics reported strong financial results for Q4 and full year 2007, with consolidated revenues growing 14.3% to $1.8 billion in Q4. Operating margin grew to 17.6% and cash flow was $355 million for the quarter.
2) For 2008, Quest expects revenue growth of approximately 9%, operating income as a percentage of revenues to approach 17%, cash from operations of $900 million, and diluted EPS between $3.00-$3.20, excluding potential special charges.
3) Quest aims to grow revenues above industry rates, expand operating income to 20% of revenues, and derive 10% of revenues from international business within 5 years. The company is well
Impax provides a summary of its business and priorities for 2017. It has a specialty pharmaceutical division focused on branded CNS products including Rytary for Parkinson's disease. Its generics division has a diversified portfolio of 72 commercial products. For 2017, Impax aims to focus on quality, execute growth initiatives for specialty products, maximize profits from generics, launch new generics, and further diversify and reduce expenses.
Sovereign Bancorp reported financial results for the fourth quarter and full year of 2007. For Q4, the company reported a net loss of $1.6 billion compared to a net loss of $129 million in Q4 2006, primarily due to goodwill impairments. For the full year, Sovereign reported a net loss of $1.3 billion compared to net income of $137 million in 2006. The company is taking steps to strengthen its capital position such as discontinuing its dividend and reducing expenses. Sovereign's non-performing loans increased and net interest margin expanded in Q4.
Sovereign Bancorp reported first quarter 2008 results with net income of $100.1 million, up from $48.1 million in the first quarter of 2007. Key highlights included an increase in net interest margin to 2.88% and loan growth of 1.9%. Non-performing loans increased to $417.8 million due to higher non-performing commercial loans related to the housing market. The allowance for credit losses was increased to 1.36% of total loans. Sovereign's President and CEO stated that results demonstrate progress reducing risk and improving earnings quality, but that turbulent financial markets provide a challenging credit environment.
This document summarizes a conference call by Quest Diagnostics about their third quarter 2005 financial results. Key points include:
- Revenues grew 6.4%, earnings per share were $0.66, and cash flow was $178 million.
- Clinical testing revenues grew 7.1% due to increased volume and revenue per test. Hurricanes Katrina and Rita reduced revenues by 0.5%.
- Operating income was 17.7% of revenues compared to 18% last year. Margins increased in clinical testing but were reduced by hurricanes and a $6.2 million charge.
- Their test kit manufacturing subsidiary NID performed below last year, reducing revenue growth by 0.5% and margin expansion
United Health Group[PDF Document] Earnings Releasefinance3
UnitedHealth Group reported first quarter 2008 results, with revenues increasing 7% to $20.3 billion and people served growing by 2 million to 73 million. Operating margin was 8.4% and net earnings per share grew 5% to $0.78. However, the company reduced its full-year 2008 outlook by 10% to a range of $3.55-$3.60 per share due to higher than expected medical costs and lower investment income. The company remains committed to $4 billion in share repurchases for 2008.
Fifth Third Bancorp reported an 11% increase in fourth quarter earnings per share compared to the same period last year. Net income for the fourth quarter totaled $423 million, a 10% increase over fourth quarter 2001. For the full year 2002, earnings per share increased 48% over 2001. The bank experienced strong customer and deposit growth, solid revenue and loan growth, and consistent credit quality. Looking ahead to 2003, the bank expects continued positive growth while remaining prepared for economic challenges.
The document provides an earnings summary and outlook for Q2 2016. Key points include:
- Adjusted EPS was above guidance despite a challenging macro environment.
- Transportation orders remained solid while Industrial orders grew quarter-over-quarter.
- Guidance for Q3 2016 projects adjusted EPS growth of 14% year-over-year.
- Full year 2016 guidance reiterates sales of $12.1-12.5 billion and adjusted EPS of $3.90-4.10.
UGI Corporation reported record results for the first quarter of fiscal year 2017. Adjusted earnings per share increased 42% compared to the prior year period, driven by higher adjusted net income across all four business units. AmeriGas Propane reported a 3.6% increase in retail volumes and $4 million decrease in operating expenses despite warmer weather. UGI International benefited from increased bulk volume due to colder weather. Midstream & Marketing saw higher margins from natural gas and capacity management. Utilities reported a 32.2% increase in core market volumes and margin growth from higher rates. Overall, strong execution and contributions from strategic investments led to the company's best ever first quarter financial performance.
Owens Corning presented at an investor event on June 13, 2017. The presentation focused on Owens Corning's commitment to shareholder value and provided an overview of the company's three business segments. Owens Corning has improved its portfolio and financial profile in recent years through cost reductions, acquisitions, and growth in higher-margin businesses. This has increased the company's adjusted EBIT margins and return on capital. Owens Corning also has a strong cash flow outlook and disciplined capital allocation strategy to support growth and return cash to shareholders.
This document provides a summary of Malibu Boats' third quarter fiscal 2017 earnings results. It reported record third quarter net sales, units sold, net income and adjusted EBITDA. Net sales increased 12.6% year-over-year due to price increases and lower discounts offsetting a mix shift to new models. Gross profit grew 16.1% and gross margin increased to 27.7%. The US boating industry recovery continued in 2016 with over 11% growth, and Malibu Boats expects to continue expanding its market share leadership. For the full fiscal year, the company targets mid-single digit unit volume growth and modest increases in adjusted EBITDA margin and net sales per unit.
Aon reported strong results for the first quarter of 2017. Organic revenue grew 4%, operating margin expanded 220 basis points to 22.3%, earnings per share increased 20% to $1.45, and free cash flow grew 38% to $148 million. Aon is a leading global professional services firm that provides risk, retirement, and health solutions using proprietary data and analytics to help clients reduce volatility and improve performance.
- TE Connectivity reported record Q3 adjusted EPS of $1.08, up 20% year-over-year and above guidance.
- Sequential increases in revenue of 6% and orders of 7% were driven by growth in harsh environment businesses.
- For Q4, revenue is expected to be $3.35 billion at the mid-point with adjusted EPS of $1.20, including the impact of an extra week.
- Full year adjusted EPS guidance was reiterated at $4.00, up 11% year-over-year, on slightly reduced revenue of $12.25 billion at the mid-point.
- Phillips 66 Partners LP owns, operates, develops and acquires primarily fee-based crude oil, refined petroleum products and natural gas liquids pipelines and terminals and other midstream assets.
- PSXP has a balanced portfolio of assets with long-term, fee-based contracts providing stable cash flows. Recent acquisitions and organic growth projects will further expand the portfolio.
- PSXP is targeting 30% annual distribution growth through 2018 while maintaining investment grade credit ratings and annual distribution coverage of at least 1.1x.
- Owens Corning presented at investor events in May 2017 to discuss its Q2 2017 performance and focus on shareholder value.
- The presentation discussed Owens Corning's three business segments: Insulation, Roofing, and Composites, and emphasized its leadership positions, attractive end markets, and focus on improving margins, earnings, cash flow, and return on capital through portfolio improvements.
- Owens Corning has demonstrated significant improvement in its financial profile and cash flow generation over the past several years through repositioning its business portfolio.
General investor presentation september 2017irbgcpartners
BGC Partners provides an overview of its Financial Services segment. The segment includes voice/hybrid brokerage and fully electronic trading (FENICS). In 2Q 2017, voice/hybrid accounted for 87% of segment revenues and pre-tax distributable earnings were up 38% year-over-year with margins expanding over 500 basis points. Product revenues were diversified across rates, foreign exchange, credit, and other asset classes. BGC expects regulatory reform, rising interest rates, and a growing global economy to drive further opportunities in Financial Services.
UGI reported solid second quarter results despite warmer than normal weather. Earnings per share were $1.24, down from $1.31 in the prior year quarter but above expectations. Each of the company's business units - AmeriGas, UGI International, Midstream & Marketing, and UGI Utilities - experienced warmer weather but reported increased revenues through investments in less weather-dependent operations and a focus on efficiency. For the full year, UGI expects adjusted earnings per share to be at the lower end or slightly below its guidance range of $2.30 to $2.45, an improvement over fiscal year 2016 results.
- Wal-Mart reported third quarter fiscal year 2009 results, with net sales increasing 7.5% to $97.6 billion and income from continuing operations increasing 6.6% to $3.03 billion compared to the previous year.
- US comparable store sales increased 2.7% for Walmart and 4.5% for Sam's Club. International sales grew 11.2% and segment operating income increased 10.6%.
- For the full fiscal year, Wal-Mart estimates diluted earnings per share will be between $3.42-$3.46, lowered from previous guidance due to currency exchange rate impacts.
First quarter 2017 financial results and strategic priorities for TDS and its subsidiaries U.S. Cellular and TDS Telecom.
Key highlights include:
- U.S. Cellular reduced postpaid handset churn to 1.08%, launched new unlimited plans, and saw adjusted EBITDA rise 11%.
- TDS Telecom grew revenues across wireline, cable, and hosted/managed services segments and increased adjusted EBITDA 13%.
- Guidance for 2017 remains unchanged with goals of growing revenues, operating cash flow, and adjusted EBITDA for both companies.
- Aon reported 2% organic revenue growth in Q2 2015 for both its Risk Solutions and HR Solutions segments.
- Risk Solutions saw 4% organic growth in the Americas and solid growth in Asia, while HR Solutions saw 3% growth in both Consulting and Outsourcing.
- Operating margins increased 150 bps for Risk Solutions due to organic revenue growth and investments in data/analytics, while HR Solutions margins were flat as growth offset continued investments.
- EPS grew 11% excluding currency impacts, driven by operational improvements and share repurchases totaling $300 million.
This document outlines amended and restated bylaws for Terex Corporation. Key points include:
- Procedures for annual and special stockholder meetings, including requirements for submitting nominations of directors and proposals.
- Requirements for providing notice of stockholder meetings and fixing the record date.
- Quorum requirements and voting procedures for stockholder actions.
- Conduct of stockholder meetings and allowance for voting by proxy.
The document is a transcript of a conference call by Tenet Healthcare Corporation executives Trevor Fetter, Stephen Newman, and Biggs Porter on May 6, 2008 to discuss the company's financial results for the first quarter. Some key points:
1) Tenet saw positive same-hospital admissions growth for the second consecutive quarter and improved EBITDA margins, signs that the company's strategies are taking effect.
2) Physician recruitment efforts increased medical staff numbers and admissions from targeted physicians. Commercial pricing also improved due to contract negotiations.
3) Cost control measures helped boost profits. April volumes showed continued growth in admissions and outpatient visits.
4) Financial results met or exceeded expectations, putting Ten
pulte homes BCF65EEF-0BFE-4C58-8C84-345ECA968DBA_phm_Q42008WebcastSlidesfinance42
- Pulte maintained its strategic focus on strengthening its balance sheet in 4Q 2008 as market conditions deteriorated, increasing cash by $500M to $1.655B despite a $42M reduction in overhead costs and lowering lots under control by 23% to 121,000 units.
- 4Q 2008 revenue fell 43% to $1.7B and pre-tax loss was $479.7M compared to a $453.8M loss in 4Q 2007, with a net loss per share of $1.33 versus $3.46 in the prior year.
- $380M of inventory and land-related impairment charges were incurred in 4Q 2008, with backlog falling to 2
This document provides financial information for SLM Corporation for quarters ending December 31, 2006, September 30, 2006, and December 31, 2005 and years ending December 31, 2006 and December 31, 2005. It includes selected financial information such as net income, earnings per share, and return on assets calculated on a GAAP and "Core Earnings" basis. It also provides details on average and ending loan balances, interest income and expense, net interest income, and provisions for losses.
The document is a supplemental earnings disclosure from SLM Corporation (Sallie Mae) for the quarter ending June 30, 2008. Some key details:
- For the quarter, Sallie Mae reported a GAAP net income of $266 million compared to a net loss of $104 million last quarter and net income of $966 million the same quarter last year.
- On a non-GAAP "Core Earnings" basis, Sallie Mae reported net income of $156 million for the quarter compared to $188 million last quarter and $189 million the same quarter last year.
- Average managed student loans for the quarter were $171.9 billion, up slightly from the previous quarter but
Tenet Healthcare Corporation reported financial results for the second quarter of 2008, with a net loss of $15 million compared to a net loss of $30 million in the second quarter of 2007. Same-hospital admissions increased 1.9% year-over-year, the strongest growth in four years, driven by growth in commercial managed care admissions. Adjusted EBITDA increased 4.5% to $163 million. Tenet maintained its outlook for 2008 and $1 billion adjusted EBITDA target for 2009.
This document is SLM Corporation's annual report (Form 10-K) filed with the SEC for the fiscal year ending December 31, 2004. It provides an overview of SLM Corporation's business operations, financial results, risks, and other disclosures required by the SEC. Key details include that SLM Corporation operates in the student loan industry, primarily originating and servicing Federal Family Education Loan Program loans. It also discusses various loan types, income sources such as floor income, and risk factors that could impact financial performance.
The document summarizes KBR's acquisition of BE&K, Inc. for $550 million in cash. BE&K is an engineering, construction, and facilities services company with $2 billion in annual revenue and backlog. The acquisition expands KBR's construction, industrial services, and engineering capabilities. It doubles the size of KBR's industrial services and provides a commercial construction presence. The transaction is expected to be earnings neutral in 2008 and accretive thereafter, while achieving revenue and cost synergies.
The document discusses Tenet Supply Chain Management's efforts to reduce costs. It describes the Medication Use Management program which uses strategies like evaluation, standardization, and utilization review to address high pharmacy spending therapeutic categories like antimicrobials and cardiovascular drugs. It also details initiatives to reduce costs for anticoagulants and hematopoietics. The MUM program has helped decrease Tenet's annual pharmacy spend over the last 4 years. Additionally, the document outlines Tenet's approach to rising orthopedic implant costs which includes custom pricing and educating surgeons, resulting in anticipated cost reductions of over $4 million in 2008.
This annual report summarizes the financial performance in 2000 of USA Education, Inc., a company that provides student loans and related financial services. Some key highlights include operating income increasing 21% to $492 million compared to 1999, managed student loans growing 27% to $67.5 billion, and student loan origination through their own systems growing 42%. The report discusses their strategic focus on direct origination through school partnerships and improving the customer experience to continue strong financial results and better achieve their mission of making education affordable.
dana holdings AuditCommitteeAccountingComplaintsPolicy_013108finance42
The Dana Holding Corporation Audit Committee Policy establishes procedures for receiving, reviewing, and addressing complaints regarding accounting and auditing matters. Employees can submit complaints confidentially and anonymously to the Audit Committee or an ethics helpline. The Office of Business Conduct will review complaints and determine if further investigation is warranted. Investigations will be conducted and results reported to the Audit Committee. No retaliation will occur against employees who report issues in good faith. Records of complaints will be retained for three years.
Sallie Mae achieved record results in 2005, its first year as a fully private company. It originated over $21 billion in preferred-channel loans and over $6 billion in private education loans. Its portfolio of managed federal loans exceeded $100 billion. It also grew its fee-based businesses such as debt management, which served federal, state, and education clients. The company aims to continue fulfilling its mission of increasing access to higher education as demand for college rises.
- Tenet Healthcare Corporation filed an amended quarterly report on Form 10-Q/A with the SEC to restate its financial statements for the quarter ended June 30, 2005.
- The restatements were based on an independent investigation that found issues with the company's accounting for contractual allowances.
- In addition to restating financial results, the report provides explanatory notes about the restatements and updates the status of the SEC's investigation into the company's contractual allowances accounting.
The document outlines the Compensation Committee Charter for Terex Corporation. It establishes the purpose, membership, responsibilities and authority of the Compensation Committee. The Committee is responsible for approving and evaluating executive compensation plans, reviewing and determining CEO compensation, overseeing regulatory compliance regarding compensation, and reporting on executive compensation in the company's proxy statement. It must meet at least quarterly and work with other Board committees on compensation and management evaluation matters.
Tenet Healthcare Corporation reported financial results for the third quarter of 2006 with a net loss of $89 million compared to a net loss of $401 million in the third quarter of 2005. Admissions declined 3.3% year-over-year due to actions under Tenet's Targeted Growth Initiative and new Medicare admission criteria. Revenues decreased 1.5% to $2.117 billion due to increases in discounts provided to uninsured patients. However, pricing increases partially offset the impact of declining volumes, with net inpatient revenue per admission increasing 4.5% after adjusting for discounts provided to uninsured patients.
dana holdings CADF2722-6DAB-4150-AF59-82832D202677_Barclays021009finance42
Dana Holding Corporation presented at the Barclays Capital Industrial Select Conference on February 10, 2009. The presentation focused on Dana's key priorities in 2008, which included rebuilding its team with new leadership, jump-starting operations through cost reduction initiatives, addressing strategic issues, and improving financial performance. Dana outlined actions taken in each area, including leadership changes, plant closures and workforce reductions, and aggressive pricing negotiations. The presentation also provided an overview of Dana's diverse markets, geographic revenues, customers, and debt maturity profile as context.
Tenet Healthcare Corporation operates 80 general hospitals across 13 states in the United States. In 2004, Tenet announced plans to divest 27 hospitals to focus resources on remaining core operations. By the end of 2004, Tenet had completed the divestiture of 18 hospitals and entered agreements to divest 4 more. Going forward, Tenet will focus on its remaining 69 general hospitals and related operations. Tenet aims to provide quality healthcare and adapt its strategies to changes in the regulatory and economic environment.
This document provides a 3-page annual report for SAIC, a technology and engineering company, for their 35th anniversary in 2004. It summarizes SAIC's history and accomplishments over 35 years, including helping analyze nuclear weapons, undertaking projects in nuclear energy and healthcare, and solving difficult problems for customers in many fields. It discusses SAIC's continued commitment to employee ownership and customer focus. The message to stockholders outlines SAIC's strategies under new CEO Ken Dahlberg to better serve customers, recommit to traditional values, and drive continued growth, including reorganizing into fewer customer-focused units and setting a goal to double the company's value in 5 years.
- SLM Corporation will hold its Annual Shareholders' Meeting on May 15, 2003 at 11:00 am at its offices in Reston, Virginia.
- Shareholders are being asked to vote on electing the Board of Directors, amending the corporation's certificate of incorporation to increase authorized shares, and ratifying the appointment of PricewaterhouseCoopers LLP as independent auditors.
- Shareholders who owned stock as of March 17, 2003 are eligible to vote, and the meeting details and voting procedures are provided.
Trevor Fetter provides an overview of Tenet Healthcare Corporation's strong fourth quarter 2008 operating results despite challenges in the broader economic environment. He highlights progress made in physician recruitment, outpatient business stabilization, targeted growth initiatives, and quality achievements. Fetter also discusses steps taken to strengthen the balance sheet through a debt refinancing and expectations for a challenging 2009 with revenue uncertainties but a guidance range of $735-800 million in adjusted EBITDA. Stephen Newman then reviews volume performance and growth strategies by service line.
The document provides a summary of a conference call discussing Tenet Healthcare Corporation's financial results for Q4 2008.
1) Tenet reported strong operating results for Q4 2008, with improvements in same-hospital volumes, revenues, and profits. However, Tenet's stock price declined sharply in Q4.
2) Despite economic uncertainties, the speaker remains optimistic about Tenet's business fundamentals due to progress in physician recruitment, outpatient business stabilization, growth in targeted service lines, and quality achievements.
3) Tenet expects its 2009 adjusted EBITDA to range from $735 million to $800 million, either flat or up 9% from 2008, due to uncertainties around volumes, payor
Tenet Healthcare reported strong operating results for Q4 2008 despite challenges from the weak economy. Same hospital metrics like admissions, outpatient visits, and revenues improved. However, the stock price declined sharply in Q4. Tenet has taken actions to improve physician recruitment and quality of care. For 2009, Tenet expects adjusted EBITDA in the range of $735 million to $800 million, flat to 9% growth over 2008. Tenet will focus on managing volumes, costs, and capital expenditures prudently given economic uncertainties. Physician recruitment exceeded targets and new physicians are contributing to volume growth. Cost control was strong in Q4 and pay-for-performance programs will provide $7 million in new revenues. Ten
The document is the prepared remarks from Tenet Healthcare Corporation's President and CEO and COO for their Q3 2007 earnings call. Some key points:
- Tenet reported their best performance in several years for Q3, with improving trends in volumes, pricing, costs, and other metrics.
- Same hospital admissions declined slightly but commercial managed care admissions increased, driven by the Targeted Growth Initiative.
- Cost control efforts like job reductions and supply cost management helped control expenses.
- They aim to achieve their guidance range for full year adjusted EBITDA of $675-725 million based on the strong Q3 results.
- Trevor Fetter, CEO of Tenet Healthcare, provided commentary on the company's Q3 earnings call. While same-hospital admissions grew for the 4th consecutive quarter, earnings did not meet expectations.
- EBITDA was below projections due to an unexpected decline in commercial managed care admissions, despite successes in growing government volumes. Tenet saw strength in volumes but weakness in patient mix.
- Looking ahead, Tenet expects adjusted EBITDA for 2008 to be in the range of $700-750 million, below prior guidance, due to a weaker starting point. The $1 billion EBITDA target for 2009 will be difficult to achieve given the weakening economy.
Tenet's COO provided an update on the company's strategies to improve volume growth. Early results from their Physician Sales and Service Program (PSSP) showed a 3.5% increase in admissions for targeted physicians. Their Centers of Excellence (COE) strategy led to a 22% increase in cardiology volumes for designated hospitals. The COO summarized their strategy as: 1) Identifying physician needs through research, 2) Accelerating capital spending on physician priorities, 3) Fine-tuning PSSP communications, and 4) Enhancing their value proposition through COE designations. The COO expressed optimism that continued momentum with PSSP and COE, along with quality initiatives, can achieve net
This document contains the prepared remarks from Quest Diagnostics' third quarter 2006 conference call. [1] It discusses Quest's strong financial results for Q3 2006, including 16% revenue growth and 21% earnings growth. [2] It provides details on revenue, volume, and margin performance. [3] It also addresses Quest's ongoing contract dispute with UnitedHealthcare and Quest's strategies for retaining United business and continuing to drive growth organically and through acquisitions.
Tenet reported disappointing financial results for Q2 2007 due to weak patient volumes and rising uncompensated care costs. While volumes bounced back in July, the company adjusted its financial outlook downward. Tenet is pursuing strategies around quality improvement, targeted growth initiatives, physician relationships, operational effectiveness, and building its outpatient business to drive longer term success, though progress has been slower than expected.
The document is Trevor Fetter, President and CEO of Tenet Healthcare's, prepared remarks from an earnings call on February 27, 2007. Fetter discusses Tenet's accomplishments in 2006 including resolving legal issues, settling insurance claims from Hurricane Katrina, and appointing new executives. He provides an outlook for 2007 of $700-800 million in EBITDA and discusses strategies like targeted growth initiatives and increased capital expenditures to drive volume growth. Stephen Newman, Chief Operating Officer, then discusses executing on these strategies including improving outpatient services to further increase volumes and performance.
- Quest Diagnostics reported strong financial results for Q2 2006, with revenues increasing 15% and EPS growing to $0.78 excluding impacts from NID.
- Organic growth was driven by increases in gene-based women's health tests, cardiovascular tests, and allergy testing. The acquisition of Focus Diagnostics further strengthened esoteric testing.
- Guidance for 2006 was reiterated with revenues expected to grow 15% and operating income margins of 17.5%, excluding discontinued operations from NID.
Quest Diagnostics reported financial results for the second quarter of 2007. Revenue grew 3.7% to $1.6 billion compared to the prior year, with acquisitions contributing approximately 6.5% of growth. Operating margin improved to 16.6% of revenues compared to 13.8% in the previous quarter, due to cost reduction efforts and higher revenue per test. The company expects margins to continue improving for the rest of the year as cost savings are realized and new contracts with health plans generate additional business.
Quest Diagnostics held a conference call to discuss its financial results for the second quarter of 2008. The call began with introductory remarks noting some statements may be forward-looking and cautioning investors. Surya Mohapatra then stated the business performed well, with double digit revenue and earnings growth. Revenue was $1.8 billion, up 12%, and earnings per share increased 14%. Cash flow also improved. Bob Hagemann then reviewed the financial results in more detail, noting continued revenue, volume, and earnings growth. He also provided an update on cost reduction initiatives and guidance for the full year.
Tenet Healthcare's Q4 2007 earnings call prepared remarks highlighted key positives in the company's performance. This included generating positive admissions growth for the first time in nearly four years, continued improvements across several leading indicators, and strengthened positioning through new managed care contracts. The company also saw improvements in quality metrics, physician recruitment, pricing gains, and cost controls. While cash flow from working capital was lower than planned, overall adjusted EBITDA came in as expected, positioning Tenet well for continued progress in 2008-2009.
1) Quest Diagnostics had an excellent first quarter with revenues growing 18%, earnings per share growing 13%, and strong cash generation of $241 million.
2) The company is seeing benefits from investments in new and innovative tests that are enhancing its value proposition.
3) After consideration, Quest decided to discontinue operations at its struggling test kit manufacturing subsidiary NID, which will reduce ongoing losses but result in restructuring charges in the second quarter.
This paper will cover an analysis of the financial statements of the fictitious Patton-Fuller Hospital for the years of 2008 and 2009. The analysis is bases on the Balance Sheets and the Statements of Revenue and Expenses for the above years along with the written annual report.
The document provides prepared remarks from the Q1 2007 earnings call of Tenet Healthcare.
[1] Tenet's COO discussed strategies to improve performance, including focusing on quality care, growing volumes, retaining employees/physicians, and cost management.
[2] Performance was mixed by region, with growth in California and Texas but declines in Florida due to new competition and aging physician base.
[3] Strategies like physician sales programs and centers of excellence designations showed benefits, but consistent execution is needed, especially in Florida.
Tenet's Q3 2006 earnings call addressed two headwinds facing the company - weak volumes and high bad debt expense. The CEO discussed macro trends in the health benefits area contributing to these problems, including fewer employers offering coverage, fewer employees receiving employer coverage, and employers shifting more costs to employees. The CEO and COO then outlined various initiatives Tenet is taking to address these issues in the areas of bad debt, volumes, quality, and physician alignment. For volumes, preliminary October data showed a 1.2% admission increase after declines in prior quarters. Regarding quality, centers of excellence designations were correlated with higher volume growth in certain service lines like cardiology.
cardinal health Q1 2008 Earnings Transcriptfinance2
Cardinal Health reported solid financial results for Q1 2008, with sales up 5% and operating earnings up 9%. However, the Supply Chain Pharma segment performed below expectations, with market factors and poor execution dampening growth. Clinical and Medical Products continued its strong growth, with revenues up 25% and profits up 60%, driven by demand for medication management and infection prevention technologies. While disappointed in Supply Chain Pharma, Cardinal is making changes to improve execution and remains on track to meet full-year EPS guidance, expecting improved performance in the second half from increased generics and operational improvements.
Quest Diagnostics reported strong financial results for the first quarter of 2005, with revenues growing 5.1% and earnings per share growing 19%. The company is focused on three strategic areas: patients, growth, and people. For patients, the company is improving service quality and the patient experience. For growth, the company is investing in services, sales, and new tests. For people, the company is investing in employee training and tools. The company expects to meet its 2005 goals of 5-6% revenue growth, operating income as a percentage of revenues of 18-19%, and 14-16% earnings per share growth.
- The document is the transcript from 3M's Q1 2006 earnings conference call.
- 3M had strong sales growth of 8.3% in Q1 2006, with all six business segments growing. Operating income grew 18.8%.
- Geographic growth was strong, with Asia Pacific growing 12.0% and Europe growing 7.9% in local currency.
SAIC's employees are dedicated to delivering innovative solutions to support clients worldwide, particularly those on the front lines of homeland security and the war in Iraq. The document discusses several ways SAIC supports homeland security, including through emergency preparedness and response training, securing borders and transportation, and responding to nuclear, biological, and chemical threats. SAIC has extensive experience supporting government agencies and was chosen to integrate the new Department of Homeland Security's data network.
SAIC delivered strong financial and technical performance in fiscal year 2005. Revenues increased 23% to $7.2 billion and operating income rose 24%. SAIC won many new contracts and saw record contract awards and backlog. Going forward, SAIC aims to capture larger systems integration contracts while maintaining an entrepreneurial culture and pursuing new opportunities in areas like digital oilfield technology. SAIC also seeks to strengthen workforce diversity and development.
The document is SAIC's annual report for fiscal year 2006. It summarizes SAIC's financial performance for the year, highlighting increased revenues of $7.8 billion, net income of $927 million, and diluted earnings per share of $5.15. It also outlines SAIC's strategic business areas of homeland security, intelligence solutions, defense transformation, logistics and transportation, systems engineering and integration, and research and development. The report discusses SAIC's response to hurricanes Katrina and Rita and its commitment to customers, employees, and shareholders.
SAIC provides technical solutions and operational support to government agencies and commercial customers in key areas such as homeland security, intelligence, defense, logistics, and IT. In fiscal year 2007, SAIC achieved revenue growth of 7% and operating income growth of 19% while making strategic acquisitions to expand capabilities. SAIC is committed to executing strategies to accelerate organic growth, expand operating margins, and make additional strategic acquisitions.
1) SAIC achieved strong financial results in FY2008, with revenues of $8.94 billion, up 11% from FY2007, and operating income of $666 million, up 16% from the previous year.
2) SAIC completed strategic acquisitions to expand in energy, infrastructure, and environment areas and appointed a new COO, Larry Prior, to lead organizational transition efforts.
3) Project Alignment is a major multi-year initiative to improve performance by integrating HR, finance, IT and other functions into a shared services model across the company.
The document provides an overview of Terex Corporation for a May 2008 investor conference. It discusses Terex's purpose, mission, and vision. It summarizes Terex's sales, operating profit, and geographic diversity for 2007. It also outlines goals to achieve $12 billion in sales and 12% operating margin by 2010. Finally, it discusses opportunities to improve margins through pricing actions, supply management, productivity initiatives, and The Terex Way values.
The document provides an overview of Terex Corporation and its business segments for an investor conference. It summarizes that Terex has a diversified portfolio across industries and geographies that provides balance through economic cycles. It also outlines opportunities to improve margins through pricing actions, supply management initiatives, and productivity improvements. The goal is to achieve $12 billion in sales and a 12% operating margin by 2010.
The document provides an overview of Terex Corporation for a Merrill Lynch conference. It discusses Terex's purpose, mission, and vision. It also summarizes Terex's diversified business segments and product lines, with aerial work platforms, construction equipment, cranes, material processing and mining equipment being the largest segments. The document outlines Terex's goals for 2010 of achieving $12 billion in sales and 12% operating margins.
The document provides an overview of Terex Corporation from its Basics Industrials Conference presentation on May 8, 2008. It discusses Terex's purpose, mission, and vision. It highlights Terex's strong and diversified revenue base, with income from operations increasing 36% in 2007 and 28% in Q1 2008. It outlines Terex's goals for 2010 of $12 billion in sales and 12% operating margin. The document also provides an overview of each of Terex's business segments.
Terex Corporation provides forward-looking statements and non-GAAP measures in their presentation. Their purpose is to improve people's lives around the world through their construction equipment. Their mission is to delight customers with high-quality products and services that exceed expectations. Their vision is to be the most customer-responsive, profitable, and desirable place for employees to work in the industry. Terex has a strong and diversified revenue base globally, with income and sales growing significantly in recent years. They are the 3rd largest construction equipment manufacturer in the world, with over 75% of sales where they have a strong market presence.
The annual shareholder meeting presentation covered the following key points in 3 sentences:
Terex aims to achieve $12 billion in sales and 12% operating margin by 2010 through executing on supply chain management, pricing discipline, and lean initiatives to improve margins. The company has a diverse portfolio of products and geographic presence to balance performance across economic cycles. Opportunities for margin improvement include coordinating supply efforts, optimizing manufacturing footprint, and pricing actions to offset rising costs.
1) The annual shareholder meeting presentation discusses Terex Corporation's financial goals for 2010, including achieving $12 billion in sales with a 12% operating margin and 15% working capital to sales ratio.
2) It provides an overview of Terex's business segments and their market positions, with approximately 75% of sales generated in markets where Terex has a leading position.
3) The presentation highlights Terex's sales and backlog figures by business segment for the last twelve months through March 2008, with aerial work platforms sales up 9% and cranes sales up 26% compared to the prior year.
This document contains the presentation from Tim Ford, President of Terex Aerial Work Platforms, at the JPMorgan Basics & Industrials Conference on June 4, 2008. Ford discusses the strong sales growth and global expansion of Terex AWP over the past decade. He outlines the secular growth drivers of the aerial work platform industry and Terex AWP's strategy to further strengthen and globalize its business, maximize revenue and profit from its large installed base, and extend its product offerings beyond aerials. Ford also highlights opportunities to apply lean principles more broadly across the value chain through partnerships with customers and suppliers.
Terex Corporation provides forward-looking statements and non-GAAP measures in their presentation. Their purpose is to improve people's lives around the world through their construction equipment. Their mission is to delight customers with high-quality products and services that exceed expectations. Their vision is to be the most customer-responsive, profitable, and desirable place for employees to work in the industry. Terex has a strong and diversified revenue base globally, with income and sales growing substantially in recent years. They are the third largest construction equipment manufacturer in the world, with over 75% of sales where they have a strong market presence.
This document contains the presentation from Tim Ford, President of Terex Aerial Work Platforms, at the JPMorgan Basics & Industrials Conference on June 4, 2008. Ford discusses the strong sales growth and global expansion of Terex AWP over the past decade. He outlines the secular growth drivers for the aerial work platform industry and Terex AWP's strategies to further strengthen and globalize its business, maximize revenue and profit from its large installed base, and extend its product offerings beyond aerials. Ford also highlights opportunities to apply lean principles more broadly across the value chain and customer relationships.
Terex is a leading manufacturer of construction and mining equipment with strong market positions. It aims to grow sales to $12 billion by 2010 through executing on initiatives to improve supply chain management, pricing discipline, and productivity. Terex has a diversified business across products and geographies to balance performance through different economic cycles.
Terex is a leading manufacturer of construction and mining equipment with sales of $9.1 billion in 2007. It aims to grow sales to $12 billion by 2010 through organic growth and acquisitions while improving operating margins to 12% and reducing working capital to sales ratio to 15%. Terex has a diversified business across products and geographies that provides balance throughout the economic cycle.
Terex is the 3rd largest manufacturer of construction equipment in the world based on last twelve months of available Construction Equipment Sales. Terex has a strong and diversified revenue base with almost 70% of 2007 sales generated outside of the USA. Approximately 75% of 2007 sales were generated in markets where Terex has a larger market presence than competitors and/or a significant market share.
Sales and backlog for Terex's business segments through March 31, 2008:
- Aerial Work Platform sales increased 9% with backlog up 4% from the previous period.
- Crane segment sales rose 26% and backlog grew 70% over the same period.
- Material Processing & Mining sales were flat while backlog declined slightly.
Overall, Terex is experiencing growth across most segments though some backlogs decreased slightly from the prior period.
1) Terex is the 3rd largest manufacturer of construction equipment in the world, with sales of $10.1 billion over the last 12 months.
2) Terex aims to achieve $12 billion in sales and 12% operating margin by 2010, describing this goal as "12 by 12 in '10".
3) Terex has opportunities to improve margins through better pricing, supply chain management, and productivity initiatives. Reducing working capital, especially inventory, could free up hundreds of millions of dollars.
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...Vighnesh Shashtri
Under the leadership of Abhay Bhutada, Poonawalla Fincorp has achieved record-low Non-Performing Assets (NPA) and witnessed unprecedented growth. Bhutada's strategic vision and effective management have significantly enhanced the company's financial health, showcasing a robust performance in the financial sector. This achievement underscores the company's resilience and ability to thrive in a competitive market, setting a new benchmark for operational excellence in the industry.
Abhay Bhutada, the Managing Director of Poonawalla Fincorp Limited, is an accomplished leader with over 15 years of experience in commercial and retail lending. A Qualified Chartered Accountant, he has been pivotal in leveraging technology to enhance financial services. Starting his career at Bank of India, he later founded TAB Capital Limited and co-founded Poonawalla Finance Private Limited, emphasizing digital lending. Under his leadership, Poonawalla Fincorp achieved a 'AAA' credit rating, integrating acquisitions and emphasizing corporate governance. Actively involved in industry forums and CSR initiatives, Abhay has been recognized with awards like "Young Entrepreneur of India 2017" and "40 under 40 Most Influential Leader for 2020-21." Personally, he values mindfulness, enjoys gardening, yoga, and sees every day as an opportunity for growth and improvement.
when will pi network coin be available on crypto exchange.DOT TECH
There is no set date for when Pi coins will enter the market.
However, the developers are working hard to get them released as soon as possible.
Once they are available, users will be able to exchange other cryptocurrencies for Pi coins on designated exchanges.
But for now the only way to sell your pi coins is through verified pi vendor.
Here is the what'sapp contact of my personal pi vendor
+12349014282
2. Elemental Economics - Mineral demand.pdfNeal Brewster
After this second you should be able to: Explain the main determinants of demand for any mineral product, and their relative importance; recognise and explain how demand for any product is likely to change with economic activity; recognise and explain the roles of technology and relative prices in influencing demand; be able to explain the differences between the rates of growth of demand for different products.
What price will pi network be listed on exchangesDOT TECH
The rate at which pi will be listed is practically unknown. But due to speculations surrounding it the predicted rate is tends to be from 30$ — 50$.
So if you are interested in selling your pi network coins at a high rate tho. Or you can't wait till the mainnet launch in 2026. You can easily trade your pi coins with a merchant.
A merchant is someone who buys pi coins from miners and resell them to Investors looking forward to hold massive quantities till mainnet launch.
I will leave the what's app number of my personal pi vendor to trade with.
+12349014282
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdfcoingabbar
Introducing BONKMILLON - The Most Bonkers Meme Coin Yet
Let's be real for a second – the world of meme coins can feel like a bit of a circus at times. Every other day, there's a new token promising to take you "to the moon" or offering some groundbreaking utility that'll change the game forever. But how many of them actually deliver on that hype?
5 Tips for Creating Standard Financial ReportsEasyReports
Well-crafted financial reports serve as vital tools for decision-making and transparency within an organization. By following the undermentioned tips, you can create standardized financial reports that effectively communicate your company's financial health and performance to stakeholders.
how to sell pi coins effectively (from 50 - 100k pi)DOT TECH
Anywhere in the world, including Africa, America, and Europe, you can sell Pi Network Coins online and receive cash through online payment options.
Pi has not yet been launched on any exchange because we are currently using the confined Mainnet. The planned launch date for Pi is June 28, 2026.
Reselling to investors who want to hold until the mainnet launch in 2026 is currently the sole way to sell.
Consequently, right now. All you need to do is select the right pi network provider.
Who is a pi merchant?
An individual who buys coins from miners on the pi network and resells them to investors hoping to hang onto them until the mainnet is launched is known as a pi merchant.
debuts.
I'll provide you the what'sapp number.
+12349014282
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...sameer shah
Delve into the world of STREETONOMICS, where a team of 7 enthusiasts embarks on a journey to understand unorganized markets. By engaging with a coffee street vendor and crafting questionnaires, this project uncovers valuable insights into consumer behavior and market dynamics in informal settings."
where can I find a legit pi merchant onlineDOT TECH
Yes. This is very easy what you need is a recommendation from someone who has successfully traded pi coins before with a merchant.
Who is a pi merchant?
A pi merchant is someone who buys pi network coins and resell them to Investors looking forward to hold thousands of pi coins before the open mainnet.
I will leave the what'sapp contact of my personal pi merchant to trade with
+12349014282
Lecture slide titled Fraud Risk Mitigation, Webinar Lecture Delivered at the Society for West African Internal Audit Practitioners (SWAIAP) on Wednesday, November 8, 2023.
1. Tenet’s Q1 2006 Earnings Call Prepared Remarks
May 9, 2006
Trevor Fetter, President & Chief Executive Officer
Thank you, operator, and good morning everyone.
I trust that you’ve had an opportunity to review the press release we issued this morning with our
first quarter results. I’ll start by giving you an overview of the quarter, and then our Chief
Operating Officer, Reynold Jennings, will provide some commentary on volumes.
I hope that you’ve seen our press release regarding the action yesterday evening by the Inspector
General of HHS to exclude our hospital in San Diego from federal health programs. The IG made
that announcement after we had prepared our remarks for this morning, but Peter Urbanowicz, our
General Counsel, and I will be prepared to answer your questions about that matter during our
Q&A.
The predominant themes in the quarter continued to be weak volumes, strong pricing and good
cost control.
Three years ago, we had isolated but severe problems in pricing and clinical quality, and we had
widespread problems in cost control, litigation, investigations, governance, labor relations and
relations with uninsured patients. Since that time, we’ve either resolved, or are far along in
resolving, each one of those issues.
But as we’ve been fixing the original problems, we’ve confronted two new challenges affecting
the entire industry: bad debts and weak volumes. Today, bad debts appear to be stabilizing, while
weak volumes remain our number one concern.
As we worked to resolve the problems that we faced three years ago, we built a solid foundation
for the future. We are fighting the volume challenge with the same energy and creativity that we
brought to the problems we faced at the end of 2002, and our success in these areas demonstrates
that when our team sets out to fix something, we fix it. I am confident that we will do the same
with volumes.
Let me turn to the results for the quarter.
We generated net income from continuing operations of $15 million, or 3 cents per share, and
EBITDA of $216 million for the quarter, for a margin of 8.9 percent.
We use two different metrics to describe results in our earnings release: continuing operations
and same-hospital. Both measures are important, but I’m going to refer primarily to same-
1
2. hospital numbers in my comments, as I believe those are the greatest interest to you. Same-
hospital numbers are continuing operations excluding the six hospitals impacted by Hurricane
Katrina. Operations in the Gulf Coast region are still sufficiently impaired that to include them
in the discussion distorts the performance of our core business.
On a same-hospital basis, our EBITDA margin was 9.5 percent, a 50 basis point increase from
last year’s first quarter.
We identified five distinct items in our press release that had a net favorable contribution of $1
million. We broke these out so that you could decide which of these items should be included in
your individual assessments of our current earnings. These items include litigation and
investigation costs, impairment and restructuring charges, costs related to Katrina, our unusual
tax position and favorable adjustments from prior year cost report settlements.
As we have discussed in previous quarters, we also had a reversal of some temporary spikes in
bad debt expense from the last half of ’05, which we estimate added about $5 million, or 1 cent
per share, to earnings this quarter. I’ll take you through the details on bad debt trends in just a
few minutes.
As you know, the first quarter is typically our strongest of the year. The 3 cents we earned from
continuing operations is above the consensus estimates for the quarter, but at this point, we are
not going to refine or confirm the outlook for 2006 that we issued in March. Our practice has
been to issue an outlook only once a year, and after only one quarter it would be premature to
refine or confirm it.
Drilling down into the specifics of the quarter, let’s start with volumes. The decline in volumes
drives the outcome of virtually every other performance metric, and starting with volumes is the
only way to place the quarter’s results in context.
Same-hospital admissions declined by 3.3 percent relative to last year’s first quarter. Nearly a
third of the decline results from the deliberate elimination of service lines or operating entities.
The more serious impact on earnings came from the 5.3 percent decline in same-hospital
commercial managed care volumes.
Our acuity rose by one and a quarter percent from last year’s first quarter, and by more than a
half a percent from Q405. This was driven by increases in acuity in several of our service lines.
In cardiology, we had volume losses in the less intense procedures. Cardiology volume was
down 5 percent, but case mix was flat. In orthopedic and spine surgery, volumes were up by
nearly 3 percent and case mix was up 2 percent. In pulmonary medicine, volume was down by 6
percent, but case mix was up by 6 percent. And in general surgery, volume was down by 4
percent and case mix was up 2 percent. These were the drivers of the increase in acuity for the
quarter.
Let’s turn to pricing, where we achieved very strong results for the third consecutive quarter.
We recorded a 7.7 percent increase in same-hospital, Compact-adjusted net inpatient revenue per
admission. On the outpatient side, the comparable metric increased by 11.9 percent. While the
2
3. increase in acuity helped slightly, these aggregate increases are especially impressive as they
helped offset the adverse shift in our payor mix away from commercial managed care patients
and toward managed Medicare and Medicaid.
The real strength becomes visible when we narrow our focus to just the commercial managed
care piece of our business. For commercial managed care, net inpatient revenue per admission
increased by 11.8 percent on a same-hospital basis. Our managed care team has done an
excellent job of fixing our pricing problems and putting our hospitals on solid ground in pricing
and contract terms. The missing piece is volume, and that’s why Tenet’s profit growth is
critically dependent on volume growth. When we rebuild commercial managed care volumes,
these impressive pricing gains will be reflected on the bottom line.
If we had generated the same commercial managed care volumes in the first quarter of 2006 as in
the first quarter of 2005, we would have retained additional revenues of about $50 million with
50 to 60 percent of that adding to EBITDA for the quarter. We estimate that retaining the
managed care volume we lost over the past year would have added 110 to 125 basis points to our
EBITDA margin.
Despite the recent declining volumes in commercial managed care, our aggregate portfolio yield
on our inpatient business increased by 6.1 percent compared to the first quarter of 2005. You
will recall that in our fourth quarter, we reported a year-over-year increase of 9.7 percent for our
aggregate portfolio yield; so on a sequential basis, our improvement moderated a bit. We expect
the moderation to continue as we reach the anniversary of some of these strong quarters.
These pricing increases offset the volume declines to create 3.1 percent growth in revenues on a
same-hospital, Compact-adjusted basis.
We also continued to do a great job on cost control. Same-hospital controllable costs per
adjusted patient day actually declined by 2.8 percent from Q405 to Q106.
On a year-over-year basis, our controllable operating expense per adjusted patient day rose by
5.2 percent. Not surprisingly, the line item with the greatest increase was supply expense, which
increased 6.2 percent.
Despite a comparatively more severe decline in volumes, our growth rate in unit controllable
costs of 5.2 percent is below our peers and further demonstrates the favorable impact of our
discipline in cost control, which is now hard-wired throughout the company. Given what we’ve
accomplished in pricing and costs, we’ve set the stage for strong growth in income when we
generate growth in volumes.
Let’s move on to bad debt.
On a same-hospital, Compact-adjusted basis, our bad debt ratio was 12.9 percent for the quarter,
an increase of 110 basis points from a year ago, but a decline of 140 basis points from the 14.3
percent that we reported last quarter.
3
4. You will recall that in the past two quarters we isolated the impact of some systems conversion
issues, which caused a temporary increase in bad debt expense. We told you that as we collected
these delayed billings, we expected our bad debt ratio to show a temporary decline, reversing the
earlier increase. This quarter we collected the remainder of these amounts, which reduced the
first quarter’s bad debt ratio by roughly 20 basis points, adding an estimated $5 million to
EBITDA.
Another trend in bad debt was that more of our uninsured patients were classified as “charity.”
In part, this is due to the elimination of the adult medically indigent program in Tennessee and
the elimination of funding for undocumented immigrants in the California county where Doctors
Medical Center of Modesto is located. The elimination or reduction of similar funds in Missouri
and Georgia will continue to limit the uninsured, low income population from eligibility and
further increase our charity care.
I am highlighting this growth in charity partly because I don’t want anyone to conclude that we
are making more progress on reducing bad debt than is actually the case. The other reason to
highlight this change is to follow up on my comments last quarter about cost-shifting. Last
quarter, I talked about cost-shifting from employer to employee. Well, here’s another stark
example of cost shifting: state and county governments simply deciding not to compensate
hospitals for the care that we are providing to their residents, whom we have a federal mandate to
care for. I think it’s outrageous, and you’ve got to wonder when this situation is going to reach a
breaking point.
The number of charity inpatients increased by 30 percent from last year’s first quarter, on a
same-hospital basis to over 2,800 patients. Total uncompensated inpatient care volume, defined
as uninsured self pay and charity, rose 8 percent on a same-hospital basis since the first quarter
of last year. It’s a rough estimate, but we think that the total uncompensated care that we provide
these people is costing us about a quarter billion dollars per year. That’s cost, not charges or
foregone revenues, which of course, would be considerably higher.
Since hospitals are the primary sector of the health care economy that is bearing the
responsibility for these costs, again I’ve got to ask the question of when this situation reaches a
breaking point and gains sufficient attention in federal, state and local governments.
We also had a very active quarter on the quality front. The major national managed care
companies recognized Tenet’s advances in quality by continuing to award our hospitals’ Centers
of Excellence designations for an ever-growing number of service lines.
Last quarter, we spoke in great detail about the UnitedHealth Care designations. This quarter,
I’d like to spend some time telling you about our Cigna designations.
Cigna’s policy is to re-evaluate all service line designations on an annual basis. This year, they
expanded the number of service lines to 29 from 19, while simultaneously raising the volumes
required to be eligible.
4
5. In 2005, 41 Tenet hospitals earned 95 service line designations as Centers of Excellence from
Cigna. As of today, Tenet hospitals had achieved a 56 percent increase in Centers of Excellence
designations, bringing our total Cigna designations to 149. To receive these designations
requires the hospitals to receive 3 stars from Cigna on both patient outcomes and cost efficiency,
offering significant advantages to both the patient and the payor.
In addition to these designations, 11 of our hospitals were named Cigna Certified Hospitals for
Bariatric Surgery. Because Cigna awarded only 88 of these certifications across the country,
Tenet’s hospitals represent one-eighth of the national total. We hope that these certifications,
along with the government’s recent decision to cover some bariatric procedures, will influence
other payors to cover these surgeries going forward.
We’ve got a number of initiatives to improve quality and grow volume. Our efforts to gain these
Centers of Excellence designations are at the heart of these strategies.
To benefit from the cost efficiencies associated with these designations, some of the managed
care payors are offering to reduce deductibles or eliminate co-pays. When you factor these
incentives into the equation, the ability to link quality and efficiency to higher patient volumes
becomes very real and very exciting.
Two and a half years ago, I declared that quality would be our strategy because it was the right
thing to do. Period. But as these quality designations and plan designs intersect with
consumerism, Tenet’s investments in quality should show greater economic returns as well.
Let’s now turn to cash flow.
Cash flow used by operating activities was negative $321 million in the quarter. Including
capital expenditures of $117 million, free cash flow was negative $438 million.
While our cash consumption was large, it’s important to note that there were several unusual
items adversely impacting cash this quarter:
First, payments toward restructuring, litigation costs and settlements, and discontinued
operations totaled $183 million. This includes a $145 million payment to settle a securities class
action lawsuit and a $7 million payment to settle with Florida’s attorney general.
Second, we paid $97 million in the quarter to fund the entire 2005 401(k) matching
contributions. This is substantially more than we paid a year ago because the Q105 funding
represented only half the total 2004 contribution. We decided to change the timing of our
funding in May 2004 for contributions for the period beginning July 1, 2004, which were then
funded in the first quarter of 2005. We made this change to reduce costs and we estimate this
change will save us nearly $15-20 million annually, due to employee turnover and eligibility.
Third, our interest payments on long-term debt were $123 million. There were additional
payments of $29 million this quarter compared to the prior year due to the additional debt that
we issued in January 2005 and the timing of our interest payments.
5
6. The first quarter typically has a high cash burn, given the timing of our expenditures. If you look
at 2005, for example, you’ll see that cash flow improved in subsequent quarters during the year.
Unrestricted net cash at the end of March was $975 million. In addition, we had another $263
million in cash that’s restricted as collateral for standby letters of credit.
Now, before I turn the floor over to Reynold, I’d like to call your attention to a series of
organizational changes that we’ve made over the past few weeks. We appointed one of our
senior operations executives to lead a group to execute our outpatient growth strategy. We also
restructured our regional operations in Florida and the Southern States to better enable our
regional leaders to focus on local market business development. I’m proud that we have been
able to retain and recognize talented people from within the organization, and we’ve been able to
recruit fresh talent from other fine companies.
With that as an overview, let me turn things over to Reynold for a deeper look at some of the
volume building efforts underway in our hospitals.
Reynold Jennings, Chief Operating Officer
Thanks Trevor, and good morning.
I’d like to begin by commenting on Tenet’s inpatient volumes in the first quarter. As Trevor
mentioned, we saw a continuation of the aggregate volume decline we’ve experienced in recent
quarters. Embedded in these numbers, however, is a more complex and positive story.
Fifteen of our hospitals actually had strong year-over-year growth in patient volumes. And 11
more had volumes about even with their first-quarter results last year. In other words, 26
hospitals – or about 40 percent of our portfolio – delivered reasonably good results in the quarter.
The hospitals with the strongest growth were in Birmingham, Atlanta, Omaha, St. Louis,
Memphis, the Carolinas and parts of Florida. Since many of these are historically among our
strongest margin hospitals, we see this as good news.
On the other side of the coin, 14 of our hospitals – or about 20 percent of the portfolio –
accounted for about 90 percent of our aggregate, year-over-year decline in volumes. This group
included hospitals in Florida, California and Texas. Let me give you some detail about what
affected these hospitals in the quarter:
A. In Florida, the combination of a warm winter in the Northeast, and extensive damage from
Hurricane Wilma seriously reduced tourism in the state, as well as the number of snowbirds
who usually spend the winter there. These factors, along with a weaker than normal flu
season, resulted in fewer admissions at five of our Florida hospitals. Also, hurricane damage
to condo projects forced some, mostly elderly residents who live in the communities served
by two of our hospitals, to find temporary housing outside the area. However, we believe
that situation will reverse itself shortly.
6
7. B. In California, our targeted growth initiative’s planned de-emphasis of certain service lines
accounted for about half of the volume decline there. We attribute the other half to our
decision at two California hospitals to reject the unacceptably low capitation rates in a new
contract offered by two large medical groups.
C. In Texas, two hospitals we lease in Dallas accounted for 24 percent of the volume decline in
that state. Business at those hospitals – Trinity and RHD Memorial – has been hurt this year
by the uncertainty generated after their owner, the Metrocrest Hospital Authority, sought
competitive bids to manage them once our lease expires in 2007. The balance of our volume
decline in Texas was primarily the result of stiff competition from four new and maturing
hospitals in Dallas and Houston.
So, to summarize, I’d say our volume results for the first quarter show that a significant portion
of our portfolio is doing pretty well, especially in light of the general challenges faced by all
hospitals these days. Our overall volume weakness is basically caused by 14 hospitals with very
specific issues, and we are aggressively tackling those situations.
Let me now move to our Physician Sales and Service Program, which we launched last year.
The results continue to be very encouraging. Our hospital management teams have had face-to-
face meetings with about 11,000 of our 13,000 targeted doctors, and as a result, we have
identified about 1,600 individual opportunities for service improvement at our hospitals.
Based on this experience, we’ve learned that there is nothing more positive in building and
cementing relationships with our doctors than asking them to tell us about issues they have with
the hospital and then taking quick action to resolve them. The physicians continue to express
appreciation for the visits by our local hospital management teams and the efforts being made to
respond to their needs.
On our last call, I gave you some examples of the service improvement opportunities we have
identified, all of which fall into three categories: First, those that are easy to understand and
resolve; second, those that can be resolved but will take some time; and thirdly, those for which
we don’t yet have a solution.
Thematically, these opportunities fall into seven broad categories:
1. Process improvement and throughput
2. Customer service
3. Modernization of our physical plants
4. Marketing/advertising/community outreach
5. Physician recruitment
6. Effective communication between hospital administrators and physicians, and
7. Scheduling, registration and pricing of outpatient services
Some components of our Commitment to Quality initiative are already implementing significant
improvements in critical service areas such as the emergency department and surgery. With the
7
8. additional information we now have as a result our physician visits, we are focused on improving
others areas within the hospital and also boosting the spirit of collaboration with our physicians.
With regard to boosting that spirit of collaboration, let me give you three rather simple examples:
• First, physicians in one of our Houston hospitals told us that our outpatient order forms
were difficult to use. We immediately worked with the physicians to redesign the forms
and added carbonless copies to save both time and cost.
• Second, physicians in East Texas told us that a specialty group at a competing hospital
was breaking up, and that gave our hospital leaders the opportunity to recruit two of those
physicians to our hospital.
• And third, we found that the primary care physicians and endocrinologists in our El Paso
hospitals were looking for educational opportunities in bariatric surgery. They were
delighted when we quickly gave them copies of our new clinical service manual focused
specifically on bariatric procedures.
These examples should make it clear that not all physician-friendly improvements need to be
expensive. And, as an indication of how well our hospital managers are embracing the value of
the physician visitation program, I can tell you that our data clearly shows the hospitals with the
greatest volume challenges also happen to be the ones most actively using the program software
tracking tool that we’ve implemented. I’m optimistic that we have much more value to harvest
from this program.
Now let me talk about the operational effect of local hospital management stability. Of the 14
hospitals I spoke of that drove the lion’s share of our aggregate volume decline in the first
quarter, three were being managed by an interim chief executive officer and three others were
being managed by newly hired permanent CEOs.
We lost six experienced hospital CEOs in December 2005, all of whom left because they had
been recruited by larger, well-known hospital systems. I see that loss as a bittersweet
consequence of our accomplishments in public quality scores, cost control and data-enriched
decision making. Tenet’s progress in these and other operational enhancement initiatives have
made many of our hospital executives the target of executive search firms.
We are redoubling our efforts to retain our top talent, and one way we’re doing that is by making
sure our experienced hospital CEOs have a career ladder with us. Fortunately, we have been
able to replace our hospital departing hospital executives with well-qualified internal candidates
in almost half the cases. In addition, our external recruiting efforts have brought us some very
good managers from other companies and hospital systems. I am excited about both the internal
and external candidates’ enthusiasm for being a part of our future.
Before I turn it back over to Trevor, let me mention that at the end of the first quarter we had
virtually completed the latest wave of our targeted growth initiative. This involved eleven
hospitals, including the remaining two in California, five in Florida, two in the Central Northeast,
and two in Texas.
8
9. With that, I’ll hand it back over to Trevor.
Trevor Fetter, President & Chief Executive Officer
Thank you Reynold, operator, we are ready now to begin the Q&A.
[END]
9